Abstract
We report a 9-month-old male latino infant with congenital nephrogenic diabetes insipidus (NDI) who presented with hypernatremic dehydration aggravated by severe gastroenteritis. Initially, the infant was managed with intravenous fluids followed by standard 20 cal/ounce formula and pharmacological therapy, resulting in normalization of his serum sodium level. While hydrochlorothiazide therapy alone or in combination with prostaglandin inhibitors or amiloride has been successful in children and adolescents, this is the first report of the successful use of hydrochlorothiazide and amiloride in an infant with congenital NDI.
This is a preview of subscription content, log in via an institution to check access.
References
Zender HO, Ruedin P, Moser F, Bolle J-F, Leski M (1992) Traumatic rupture of the urinary tract in a patient presenting nephrogenic diabetes insipidus associated with hydronephrosis and chronic renal failure: case report and review of the literature. Clin Nephrol 38:196–202
Schofer O, Beetz R, Kruse K, Rascher C, Schutz C, Bohl J (1990) Nephrogenic diabetes insipidus and intracerebral calcification. Arch Dis Child 65:885–887
Langley JM, Balfe JW, Selander T, Ray PN, Clarke JT (1991) Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet 38:90–94
Knoers N, Heyden H van der, Oost BA van, Ropers HH, Willems J (1988) Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X chromosome. Hum Genet 80:31–38
Bichet DG, Rzai M, Arthus M, Lonergan M, Tittley P, Smiley RK, Rock G, Hirsch DJ (1989) Epinephrine and dDAVP, administration in patients with congenital nephrogenic diabetes insipidus. Kidney Int 36:859–866
Lolait SJ, O'Carroll A-M, McBride OW, Konjig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336–339
Pang Y, Metzenberg A, Das S, Jing B, Gitschier J (1992) Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nature 2:103–106
Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW (1987) Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol 1:485–490
Knoers N, Monnens LA (1990) Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr 117:499–502
Bonioli E, Bellini C (1991) Therapy for hereditary nephrogenic diabetes insipidus (letter). J Pediatr 119:331
Morgan OB, Davidson C (1980) Hypokaliemi, and diuretics: an analysis of publications. BMJ 280:905–908
Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572
Alon U, Chan CM (1985) Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 5:9–13
Ellison DH, Velazquez H, Wright FS (1987) Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol 253:F546-F555
Muther RS, Potter DM, Bennett WM (1981) Aspirin-induced depression of glomerular filtration rate in normal humans — role of sodium balance. Ann Intern Med 94:317–321
Stokes JB (1981) Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol 240:F471-F480b
Wingo CS (1985) Cortical collecting tubule potassium secretion: effect of amiloride, ouabain, and luminal sodium concentration Kidney Int 27:886–891
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uyeki, T.M., Barry, F.L., Rosenthal, S.M. et al. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus. Pediatr Nephrol 7, 554–556 (1993). https://doi.org/10.1007/BF00852546
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00852546